Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.29M Sell
178,000
-277,800
-61% -$7.27M 0.01% 1390
2026
Q1
$12.8M Sell
455,800
-122,500
-21% -$3.26M 0.02% 621
2025
Q4
$14.4M Sell
578,300
-301,200
-34% -$7.6M 0.03% 542
2025
Q3
$22.4M Sell
879,500
-809,200
-48% -$20M 0.04% 386
2025
Q2
$40.9M Buy
1,688,700
+1,612,500
+2,116% +$37.6M 0.09% 159
2025
Q1
$1.93M Buy
76,200
+64,300
+540% +$1.68M 0.01% 1370
2024
Q4
$316K Sell
11,900
-513,200
-98% -$13.9M ﹤0.01% 2546
2024
Q3
$15.2M Sell
525,100
-376,800
-42% -$11M 0.06% 256
2024
Q2
$25.2M Sell
901,900
-86,500
-9% -$2.38M 0.13% 132
2024
Q1
$27.4M Buy
988,400
+75,800
+8% +$2.1M 0.17% 89
2023
Q4
$26.3M Buy
912,600
+637,500
+232% +$19.3M 0.21% 67
2023
Q3
$9.13M Buy
275,100
+111,200
+68% +$3.93M 0.09% 269
2023
Q2
$6.01M Buy
163,900
+152,100
+1,289% +$5.92M 0.07% 354
2023
Q1
$480K Buy
+11,800
New +$510K 0.01% 1642
2022
Q1
Sell
-11,800
Closed -$697K 2510
2021
Q4
$697K Sell
11,800
-158,000
-93% -$7.83M 0.01% 1238
2021
Q3
$7.3M Buy
+169,800
New +$7.52M 0.12% 164

Other funds holding PFE

Paul Tudor Jones's PFE Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in Pfizer (PFE) in Q2 2026: 697,000 shares worth $16.8M. The stake represents 0.02% of the portfolio and ranks #570 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in PFE as recently as Q4 2025.

Paul Tudor Jones first reported a position in PFE in Q2 2013 and has held it in 39 quarters since. The position peaked at $39.6M in Q1 2015. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Paul Tudor Jones held 697,000 shares of Pfizer worth $16.8M as of Q2 2026.
  • Pfizer was a new Paul Tudor Jones position in Q2 2026.
  • Pfizer made up 0.02% of Paul Tudor Jones's portfolio in Q2 2026, its #570 holding.
  • Paul Tudor Jones first reported a position in Pfizer in Q2 2013 and has held it in 39 quarters since.
  • Paul Tudor Jones's Pfizer position peaked at $39.6M in Q1 2015.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.